Verbatim response from ChatGPT
Short answer: BHRT (bioidentical hormone replacement therapy) can be safe and effective for many people when prescribed and monitored by a clinician, but safety depends on which hormones are used, how they’re prepared and given, the dose, and a person’s individual health risks. Many doctors support use of hormone therapy (including “bioidentical” hormones that are FDA‑approved) for bothersome menopausal symptoms, but major medical societies and the FDA warn about unregulated compounded “bioidentical” products and urge individualized risk–benefit decisions.
Key points doctors and professional groups emphasize
- “Bioidentical” means the molecule is chemically identical to a human hormone (for example, 17β‑estradiol or micronized progesterone). Some of these (estradiol, micronized progesterone) are available as FDA‑approved products; others are only made by compounding pharmacies.
- Evidence supports hormone therapy for moderate–severe vasomotor symptoms (hot flashes), vaginal atrophy, and prevention of bone loss in many people around the time of menopause. Starting therapy within about 10 years of menopause or before age ~60 generally has a more favorable risk–benefit profile.
- Risks include increased risk of venous thromboembolism (VTE) and stroke (especially with oral estrogen), and an increased risk of breast cancer with combined estrogen + certain progestogens (based on the Women’s Health Initiative findings). Unopposed estrogen increases endometrial cancer risk in people with a uterus unless a progestogen is added.
- Route matters: many doctors prefer transdermal estradiol (patch or gel) for people with VTE risk because it appears to have lower VTE risk than oral estrogen.
- Compounded “custom BHRT”: major organizations (ACOG, Endocrine Society, North American Menopause Society) and the FDA raise concerns — compounded products are not FDA‑approved, may have variable potency and purity, and claims that they are safer or uniquely “natural” are not proven. Most clinicians recommend FDA‑approved products when possible.
What doctors typically recommend in practice
- If you have moderate–severe menopausal symptoms and no contraindications, hormone therapy can be offered after discussion of risks/benefits and individualized evaluation.
- Use the lowest effective dose for symptom control and reassess regularly. Duration is individualized; long‑term use may be reasonable for some after discussion of risks.
- Prefer FDA‑approved formulations when possible. If compounded therapy is considered (rarely necessary), use a reputable state‑licensed compounding pharmacy and arrange appropriate monitoring.
Examples of FDA‑approved (bioidentical) products doctors commonly use
- Estradiol (patches, gels, oral): Vivelle‑Dot, Climara, Minivelle, Alora (patches); EstroGel (gel); Estrace (oral estradiol). These contain 17β‑estradiol, the bioidentical estrogen.
- Micronized progesterone: Prometrium. This is a bioidentical progesterone formulation used to protect the endometrium in people with a uterus.
- Combined products: Some patches/pills combine estradiol with a progestogen (examples vary by country/market).
Testosterone for women
- Some clinicians prescribe low‑dose testosterone for certain women (e.g., persistent low sexual desire) but evidence and long‑term safety data are limited; most testosterone products available are not approved for women and use is off‑label or via compounding.
If you’re considering BHRT
- Talk with a clinician (gynecologist, menopause specialist, or endocrinologist) who will review your medical history (personal and family cancer history, clotting disorders, cardiovascular disease, liver disease, smoking) and discuss routes, formulations, and monitoring.
- Ask if the product is FDA‑approved or compounded and why that choice is recommended.
- If you prefer lower clotting risk, ask about transdermal estradiol.
- Consider getting baseline assessments (blood pressure, lipids, glucose as indicated) and follow‑up plans.
If you want, tell me your age, symptoms, and health history and I can summarize what options doctors would likely consider and what risks to watch for.